Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
The current price of DHRC.VI is €166.02 EUR — it has increased by +0.65% in the past 24 hours. Watch Danaher stock price performance more closely on the chart.
What is Danaher stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Danaher stocks are traded under the ticker DHRC.VI.
Is Danaher stock price growing?▼
DHRC.VI stock has risen by +4.35% compared to the previous week, the month change is a -5.78% fall, over the last year Danaher has showed a -4.61% decrease.
What is Danaher market cap?▼
Today Danaher has the market capitalization of 117.4B
When is the next Danaher earnings date?▼
Danaher is going to release the next earnings report on April 21, 2026.
What were Danaher earnings last quarter?▼
DHRC.VI earnings for the last quarter are 1.86 EUR per share, whereas the estimation was 1.81 EUR resulting in a +3.11% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Danaher revenue for the last year?▼
Danaher revenue for the last year amounts to 42.3B EUR.
What is Danaher net income for the last year?▼
DHRC.VI net income for the last year is 6.23B EUR.
Does Danaher pay dividends?▼
Yes, DHRC.VI dividends are paid quarterly. The last dividend per share was 0.27 EUR. As of today, Dividend Yield (FWD)% is 0.83%.
How many employees does Danaher have?▼
As of April 04, 2026, the company has 78,000 employees.
In which sector is Danaher located?▼
Danaher operates in the Healthcare sector.
When did Danaher complete a stock split?▼
The last stock split for Danaher was on June 14, 2010 with a ratio of 2:1.
Where is Danaher headquartered?▼
Danaher is headquartered in Washington, United States.